• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSB2200097 QM1114 botulinum toxin type A Lyophilized Biological Products(1) Supplementary Application 2022-07-26 Q-Med AB;Ipsen Biopharm Ltd view
JXSL2101084 QM1114 botulinum toxin type A Lyophilized Biological Products(1) Import Drug Application 2021-08-05 Q-MED International Trading (SHANGHAI) Co Ltd;Ipsen Biopharm Ltd view
JTS2300039 QM1114 botulinum toxin type A Lyophilized Biological Products Disposable Import Drug Application 2023-07-20 Q-MED International Trading (SHANGHAI) Co Ltd;Q-Med AB view
JXSL1300065 注射用A型肉毒毒素 botulinum toxin type A Lyophilized Biological Products Import Drug Application 2013-10-24 北京四环制药有限公司 Beijing Sihuan Pharmaceutical Co Ltd;Hugel Inc Certificate Issued 2016-05-24 view
JXSS2300053 注射用A型肉毒毒素 botulinum toxin type A Lyophilized Biological Products(2.2) Import Drug Application 2023-07-06 Shanghai Fosun Pharmaceutical Industrial Development Co Ltd;Revance Therapeutics Inc view
JYSB1000021 注射用A型肉毒毒素 botulinum toxin type A Lyophilized Biological Products Supplementary Application 2010-01-27 Allergan Pharmaceuticals Ireland Allergan Pharmaceuticals Ireland Certificate Issued 2012-03-27 view
CXSL2000359 注射用A型肉毒毒素 botulinum toxin type A Lyophilized Biological Products(3.4) New Drug Application 2020-12-16 兰州生物技术开发有限公司 Lanzhou Biotechnique Development Co Ltd In Review 2020-12-15 view
CXSL2200601 注射用A型肉毒毒素 botulinum toxin type A Lyophilized Biological Products(2.2) New Drug Application 2022-12-13 Lanzhou Biotechnique Development Co Ltd view
JXSS1900036 注射用A型肉毒毒素 botulinum toxin type A Lyophilized Biological Products Import Drug Application 2019-06-27 Hugel Inc Certificate Issued 2020-10-26 view
JYSB1600022 注射用A型肉毒毒素 botulinum toxin type A Lyophilized Biological Products Supplementary Application 2016-02-25 艾尔建信息咨询(上海)有限公司 Allergan Consulting (Shanghai) Co Ltd;Allergan Pharmaceuticals Ireland Certificate Issued 2017-08-29 view
JYSB2400142 注射用A型肉毒毒素 botulinum toxin type A Lyophilized Biological Products Supplementary Application 2024-07-02 Abbvie Ltd;Allergan Pharmaceuticals Ireland view
JYSB1200193 注射用A型肉毒毒素 botulinum toxin type A Lyophilized Biological Products Supplementary Application 2012-07-25 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Allergan Pharmaceuticals Ireland Certificate Issued 2015-03-03 view
CYSB2100063 注射用A型肉毒毒素 botulinum toxin type A Lyophilized Biological Products Supplementary Application 2021-02-26 兰州生物技术开发有限公司 Lanzhou Biotechnique Development Co Ltd Certificate Issued 2021-12-21 view
CXSL2300037 注射用A型肉毒毒素 botulinum toxin type A Lyophilized Biological Products(3.2) New Drug Application 2023-01-13 Lanzhou Biotechnique Development Co Ltd view
JXSL2000099 注射用A型肉毒毒素 botulinum toxin type A Lyophilized Biological Products Import Drug Application 2020-06-29 艾尔建信息咨询(上海)有限公司 Allergan Consulting (Shanghai) Co Ltd;Allergan Pharmaceuticals Ireland In Review 2020-06-25 view
JYSB1800042 注射用A型肉毒毒素 botulinum toxin type A Lyophilized Biological Products Supplementary Application 2018-03-21 艾尔建信息咨询(上海)有限公司 Allergan Consulting (Shanghai) Co Ltd;Allergan Pharmaceuticals Ireland Certificate Issued 2019-02-11 view
JYSB2400247 注射用A型肉毒毒素 botulinum toxin type A Lyophilized Biological Products(3.1) Supplementary Application 2024-11-30 Ajinomoto Althea Inc;Revance Therapeutics Inc view
JXSL1300040 注射用A型肉毒毒素 botulinum toxin type A Lyophilized Biological Products Import Drug Application 2013-06-18 艾尔建信息咨询(上海)有限公司 Allergan Consulting (Shanghai) Co Ltd;Allergan Pharmaceuticals Ireland Certificate Issued 2015-09-08 view
JXSL2200145 注射用A型肉毒毒素 botulinum toxin type A Lyophilized Biological Products(3.1) Import Drug Application 2022-08-26 Abbvie Ltd;Allergan Consulting (Shanghai) Co Ltd view
JYSB2300088 注射用A型肉毒毒素 botulinum toxin type A Lyophilized Biological Products Supplementary Application 2023-05-10 Abbvie Ltd;Allergan Pharmaceuticals Ireland view